Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Apr-24 6:30 PM View:  | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. Director | Nuvation Bio Inc. (NUVB) | 09-Apr-24 | Grant | 550,758 | -- | -- | 40% 1.38M to 1.93M | |
| 11-Apr-24 9:01 PM View: | Cui Xiangmin Director | Nuvation Bio Inc. (NUVB) | 09-Apr-24 | Grant | 6,172,340 | -- | -- | 100% 0 to 6.17M | |
| 11-Apr-24 6:30 PM View: | Wang Junyuan Jerry CEO, ANHEART THERAPEUTICS LTD. Director | Nuvation Bio Inc. (NUVB) | 09-Apr-24 | Grant | 1,378,990 | -- | -- | 100% 0 to 1.38M | |
| 21-Sep-23 8:08 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 21-Feb-23 | Purchase | 53,000 | $1.36 | $72,138.30 | < 1% 19.16M to 19.21M | |
| 21-Sep-23 8:08 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 20-Feb-23 | Purchase | 117,100 | $1.36 | $159,490.00 | < 1% 19.04M to 19.16M | |
| 21-Sep-23 8:08 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 19-Feb-23 | Private Purchase | 5,143,000 | $1.26 | $6,460,640.00 | 37% 13.9M to 19.04M | |
| 05-Dec-22 5:10 PM View: | Falberg Kathryn E Director | Nuvation Bio Inc. (NUVB) | 05-Dec-22 | Purchase | 43,000 | $1.95 | $83,961.80 | 21% 207.0K to 250.0K | |
| 05-Dec-22 5:10 PM View: | Falberg Kathryn E Director | Nuvation Bio Inc. (NUVB) | 02-Dec-22 | Purchase | 47,000 | $1.98 | $93,186.90 | 29% 160.0K to 207.0K | |
| 05-Dec-22 5:10 PM View: | Falberg Kathryn E Director | Nuvation Bio Inc. (NUVB) | 01-Dec-22 | Purchase | 84,959 | $1.97 | $167,599.00 | 113% 75.04K to 160.0K | |
| 05-Dec-22 5:10 PM View: | Falberg Kathryn E Director | Nuvation Bio Inc. (NUVB) | 30-Nov-22 | Private Purchase | 75,041 | $1.85 | $139,088.00 | 100% 0 to 75.04K | |
| 07-Apr-22 4:52 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 05-Apr-22 | Market Sale | 2,500,000 | $5.60 | $14,000,000.00 | (11%) 22.96M to 20.46M | (15%) |
| 17-Dec-21 5:13 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 15-Dec-21 | Market Sale | 500,000 | $10.07 | $5,035,000.00 | (2%) 23.46M to 22.96M | 6% |
| 09-Dec-21 3:59 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 07-Dec-21 | Market Sale | 1,400,000 | $9.80 | $13,720,000.00 | (6%) 24.86M to 23.46M | 2% |
| 30-Nov-21 6:07 PM View: | Nodelman Oleg Director 10% Owner | Nuvation Bio Inc. (NUVB) | 24-Nov-21 | Market Purchase | 185,026 | $7.69 | $1,422,090.00 | 1% 13.71M to 13.9M | 16% |
| 24-Nov-21 6:38 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 23-Nov-21 | Market Sale | 36 | $9.75 | $351.00 | (< 1%) 24.86M to 24.86M | 5% |
| 24-Nov-21 6:38 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 22-Nov-21 | Market Sale | 295,000 | $9.76 | $2,879,200.00 | (1%) 25.15M to 24.86M | 5% |
| 05-Nov-21 5:31 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 03-Nov-21 | Market Sale | 2,000,000 | $9.25 | $18,500,000.00 | (7%) 27.15M to 25.15M | (3%) |
| 01-Nov-21 5:01 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 29-Oct-21 | Market Sale | 45,000 | $9.27 | $417,150.00 | (< 1%) 27.2M to 27.15M | 1% |
| 01-Nov-21 5:01 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 28-Oct-21 | Market Sale | 1,015,000 | $9.60 | $9,744,000.00 | (4%) 28.21M to 27.2M | 4% |
| 30-Nov-21 6:07 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 31-Jul-21 | Market Purchase | 56,598 | $8.64 | $489,007.00 | < 1% 13.71M to 13.77M | 3% |
| 30-Nov-21 6:07 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 31-Jul-21 | Market Sale | 56,598 | $8.64 | $489,007.00 | (< 1%) 13.77M to 13.71M | (3%) |
| 13-Apr-21 5:55 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 13-Apr-21 | Market Purchase | 31,500 | $10.27 | $323,536.00 | < 1% 13.68M to 13.71M | |
| 13-Apr-21 5:55 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 12-Apr-21 | Private Purchase | 133,000 | $9.49 | $1,261,880.00 | < 1% 13.55M to 13.68M | |
| 13-Apr-21 5:55 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 09-Apr-21 | Market Purchase | 300,000 | $10.03 | $3,009,180.00 | 2% 13.25M to 13.55M | 4% |
| 30-Nov-21 6:07 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 31-Mar-21 | Market Sale | 151,544 | $10.45 | $1,583,630.00 | 1% 13.1M to 13.25M | (25%) |
| 30-Nov-21 6:07 PM View: | Nodelman Oleg Director | Nuvation Bio Inc. (NUVB) | 31-Mar-21 | Market Purchase | 151,544 | $10.45 | $1,583,630.00 | 1% 12.94M to 13.1M | (25%) |
| 01-Apr-21 5:16 PM View: | Bazemore Robert B Director | Nuvation Bio Inc. (NUVB) | 30-Mar-21 | Market Purchase | 5,000 | $9.98 | $49,899.50 | 100% 0 to 5.0K | 4% |
| 02-Mar-23 6:01 PM View: | Hung David President and CEO Director 10% Owner | Nuvation Bio Inc. (NUVB) | 02-Mar-21 | Disposition (other) | 368,408 | -- | -- | (< 1%) 58.65M to 58.28M | |
| 26-Feb-21 7:00 PM View: | Hasnain Faheem Director | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Option Exercise | 25,000 | -- | -- | 83% 30.0K to 55.0K | |
| 26-Feb-21 6:59 PM View: | Cooper Graham K Director | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Option Exercise | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 12-Feb-21 5:59 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Conversion | 8,130,100 | -- | -- | 40% 20.08M to 28.21M | |
| 12-Feb-21 8:59 PM View: | Nodelman Oleg Director 10% Owner | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Grant | 10,082,000 | $2.48 | $25,000,000.00 | 2585% 390.0K to 10.47M | |
| 26-Feb-21 7:02 PM View: | Sharp Shalini Director | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Grant | 10,000 | $10.00 | $100,000.00 | 100% 0 to 10.0K | 4% |
| 12-Feb-21 5:45 PM View: | Hung David President and CEO Director 10% Owner | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Grant | 58,645,000 | $0.34 | $20,000,000.00 | 100% 0 to 58.65M | |
| 12-Feb-21 8:59 PM View: | Nodelman Oleg Director 10% Owner | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Conversion | 2,775,000 | -- | -- | 26% 10.47M to 13.25M | |
| 26-Feb-21 7:00 PM View: | Hasnain Faheem Director | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Grant | 30,000 | $10.00 | $300,000.00 | 100% 0 to 30.0K | 4% |
| 26-Feb-21 7:02 PM View: | Sharp Shalini Director | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Option Exercise | 25,000 | -- | -- | 250% 10.0K to 35.0K | |
| 12-Feb-21 5:59 PM View: | Omega Fund V, L.P. 10% Owner | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Grant | 500,000 | $10.00 | $5,000,000.00 | 3% 19.58M to 20.08M | 4% |
| 26-Feb-21 7:01 PM View: | Bradbury Daniel Director | Nuvation Bio Inc. (NUVB) | 10-Feb-21 | Option Exercise | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 06-Jul-20 5:06 PM View: | Ecor1 Panacea Holdings, LLC Director 10% Owner | Nuvation Bio Inc. (NUVB) | 06-Jul-20 | Purchase | 390,000 | $10.00 | $3,900,000.00 | 100% 0 to 390.0K | |
| 12-Feb-21 5:56 PM View: | Vernon W Anthony Director | Nuvation Bio Inc. (NUVB) | 10-Feb-20 | Grant | 304,100 | $1.64 | $500,000.00 | 100% 0 to 304.1K |
